e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Cystic fibrosis: the balance between treatment and side-effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF)
M. M. Filewska, W. Skorupa, J. Kus, A. Pogorzelski, Z. Doniec, B. Broniarek-Samson, U. Demkow (Warsaw, Rabka, Poland)
Source:
Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Session:
Cystic fibrosis: the balance between treatment and side-effects
Session type:
Thematic Poster Session
Number:
3779
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. M. Filewska, W. Skorupa, J. Kus, A. Pogorzelski, Z. Doniec, B. Broniarek-Samson, U. Demkow (Warsaw, Rabka, Poland). Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF). Eur Respir J 2007; 30: Suppl. 51, 3779
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF)
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004
Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspective
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection
Source: Eur Respir J 2002; 20: Suppl. 38, 444s
Year: 2002
Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Detection of serum anti-endothelial cell antibodies (AECA) in COPD rats
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis
Source: Eur Respir J 2011; 37: 1503-1513
Year: 2011
Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD)
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis
Source: Eur Respir J 2009; 34: 1079-1085
Year: 2009
Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018
Anti-neutrophil cytoplasmic antibodies and immune complexes vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=91
Year: 2005
Pneumococcal antibody levels in children with cystic fibrosis (CF)
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010
Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
Late Breaking Abstract - Prevalence and clinical significance of antinuclear antibody (ANA) in IPF: analysis from ESTAIR study
Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Year: 2018
Differences between ANCA positive and negative lung fibrosis cases without vasculitis
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Occurrence of ANCA positivity in persons with silicosis
Source: Eur Respir J 2002; 20: Suppl. 38, 604s
Year: 2002
Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema
Source: Eur Respir J 2004; 24: Suppl. 48, 44s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept